title: Tachykinin receptor cross-talk. Immunological cross-reactivity between the external domains of the substance K and substance P receptors.
abstract: In the present study, we have chemically synthesized peptides which correspond to the four putative extracellular domains of the predicted substance K (SK) receptor protein and raised specific polyclonal antibodies against these peptides. These antibodies were then tested for both structural and functional recognition of epitopes on the substance P (SP) receptor on rat AR42J pancreatic cells and human IM9 lymphoblasts, which express the SP receptor, but not the SK receptor. Antibodies directed against the first, second, and fourth external domains of the predicted SK receptor recognized a 58-kDa protein on AR42J cells. This protein has a molecular weight similar to the previously demonstrated SP receptor on both AR42J cells and IM9 cells. Furthermore, antibodies against the second and fourth extracellular domains significantly inhibited specific 125I-SP binding on both AR42J and IM9 cells, and also significantly inhibited SP-induced mobilization of [Ca2+]i on AR42J cells. These data suggest that the second and fourth extracellular domains of the SK and SP receptors may share common structural motifs for ligand binding and signaling mechanism.
authors.affiliation: Howard Hughes Medical Institute Laboratories and the Department of Medicine, University of California, San Francisco 94143.
authors.forename: P
authors.initials: P
authors.lastname: Parnet
authors.forename: M
authors.initials: M
authors.lastname: Mitsuhashi
authors.forename: C W
authors.initials: CW
authors.lastname: Turck
authors.forename: B
authors.initials: B
authors.lastname: Kerdelhue
authors.forename: D G
authors.initials: DG
authors.lastname: Payan
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D003429:Cross Reactions; D000939:Epitopes / Q000276:immunology; D006801:Humans; D008214:Lymphocytes / Q000737:chemistry / Q000187:drug effects; D008969:Molecular Sequence Data; D015288:Neurokinin A / Q000502:physiology*; D010179:Pancreas / Q000166:cytology; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000276:immunology; D011487:Protein Conformation; D051381:Rats; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D012689:Sequence Homology, Nucleic Acid; D015398:Signal Transduction; D013329:Structure-Activity Relationship; D013373:Substance P / Q000502:physiology*
chemical_list: D000939:Epitopes; D010446:Peptide Fragments; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter; D013373:Substance P; D015288:Neurokinin A; D002118:Calcium